Go Pro
→ BofA: Digital Dollar Coming 2025-2030 (From Decentralized Masters) (Ad)tc pixel Free RCKTW Stock Alerts

Rocket Pharmaceuticals (RCKTW) Competitors

Rocket Pharmaceuticals logo
$0.0027 0.00 (-6.90%)
As of 12:23 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

RCKTW vs. ALVOW, APLMW, ARAV, BIAFW, and BIVIW

Should you buy Rocket Pharmaceuticals stock or one of its competitors? MarketBeat compares Rocket Pharmaceuticals with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Rocket Pharmaceuticals include Alvotech (ALVOW), Apollomics (APLMW), Aravive (ARAV), bioAffinity Technologies (BIAFW), and BioVie (BIVIW). These companies are all part of the "biotechnology" industry.

How does Rocket Pharmaceuticals compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Rocket Pharmaceuticals (NASDAQ:RCKTW) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation, media sentiment and institutional ownership.

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Rocket Pharmaceuticals N/A N/A N/A

In the previous week, Rocket Pharmaceuticals' average media sentiment score of 1.50 beat Alvotech's score of 0.00 indicating that Rocket Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Alvotech Neutral
Rocket Pharmaceuticals Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$559.42MN/AN/AN/AN/A
Rocket PharmaceuticalsN/AN/AN/AN/AN/A

Summary

Alvotech and Rocket Pharmaceuticals tied by winning 1 of the 2 factors compared between the two stocks.

How does Rocket Pharmaceuticals compare to Apollomics?

Rocket Pharmaceuticals (NASDAQ:RCKTW) and Apollomics (NASDAQ:APLMW) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, dividends, profitability and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rocket PharmaceuticalsN/AN/AN/AN/AN/A
Apollomics$8.50MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Rocket PharmaceuticalsN/A N/A N/A
Apollomics N/A N/A N/A

In the previous week, Rocket Pharmaceuticals' average media sentiment score of 1.50 beat Apollomics' score of 0.00 indicating that Rocket Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
Rocket Pharmaceuticals Very Positive
Apollomics Neutral

Summary

Rocket Pharmaceuticals and Apollomics tied by winning 1 of the 2 factors compared between the two stocks.

How does Rocket Pharmaceuticals compare to Aravive?

Aravive (NASDAQ:ARAV) and Rocket Pharmaceuticals (NASDAQ:RCKTW) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
Rocket PharmaceuticalsN/AN/AN/AN/AN/A

In the previous week, Rocket Pharmaceuticals' average media sentiment score of 1.50 beat Aravive's score of 0.00 indicating that Rocket Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Aravive Neutral
Rocket Pharmaceuticals Very Positive

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
Rocket Pharmaceuticals N/A N/A N/A

Summary

Aravive beats Rocket Pharmaceuticals on 2 of the 3 factors compared between the two stocks.

How does Rocket Pharmaceuticals compare to bioAffinity Technologies?

bioAffinity Technologies (NASDAQ:BIAFW) and Rocket Pharmaceuticals (NASDAQ:RCKTW) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk.

Company Net Margins Return on Equity Return on Assets
bioAffinity TechnologiesN/A N/A N/A
Rocket Pharmaceuticals N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
bioAffinity Technologies$5.61MN/AN/AN/AN/A
Rocket PharmaceuticalsN/AN/AN/AN/AN/A

In the previous week, Rocket Pharmaceuticals' average media sentiment score of 1.50 beat bioAffinity Technologies' score of 1.02 indicating that Rocket Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
bioAffinity Technologies Positive
Rocket Pharmaceuticals Very Positive

Summary

bioAffinity Technologies and Rocket Pharmaceuticals tied by winning 1 of the 2 factors compared between the two stocks.

How does Rocket Pharmaceuticals compare to BioVie?

Rocket Pharmaceuticals (NASDAQ:RCKTW) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, media sentiment, analyst recommendations, institutional ownership and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rocket PharmaceuticalsN/AN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Rocket PharmaceuticalsN/A N/A N/A
BioVie N/A N/A N/A

In the previous week, Rocket Pharmaceuticals' average media sentiment score of 1.50 beat BioVie's score of 0.00 indicating that Rocket Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
Rocket Pharmaceuticals Very Positive
BioVie Neutral

Summary

Rocket Pharmaceuticals beats BioVie on 1 of the 1 factors compared between the two stocks.

Get Rocket Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for RCKTW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RCKTW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RCKTW vs. The Competition

Export
MetricRocket PharmaceuticalsBiotechnology IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$3.71B$7.03B$12.96B
Dividend YieldN/A3.76%2.58%10.20%
P/E RatioN/A9.06269.9324.86
Price / SalesN/A1,267.27650.62108.28
Price / CashN/A44.9528.8937.44
Price / BookN/A17.6311.256.44
Net IncomeN/A-$13.25M$3.45B$347.39M
7 Day PerformanceN/A5.49%3.67%2.69%
1 Month PerformanceN/A-1.66%-0.49%-0.90%
1 Year PerformanceN/A61.27%77.44%23.51%

Rocket Pharmaceuticals Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RCKTW
Rocket Pharmaceuticals
N/A$0.00
-6.9%		N/AN/A$0.00N/AN/A240
ALVOW
Alvotech
N/A$0.15
flat		N/AN/A$0.00$559.42MN/A4
APLMW
Apollomics
N/A$0.02
+10.1%		N/A-28.1%$0.00$8.50MN/A59
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
BIAFW
bioAffinity Technologies
N/A$0.09
+7.1%		N/A-23.6%$0.00$5.61MN/A10

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:RCKTW) was last updated on 8/10/2026 by MarketBeat.com Staff.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Beginner’s Guide to Gold
The Ultimate Beginner's Guide to Gold IRAs Protect Your Retirement Savings Before It's Too Late With This I...
Goldco Direct, LLC | Sponsoredtc pixel
3 Ways AI Can Reshape Your Retirement For The Worse
AI-linked companies now make up an estimated 36% of major index holdings, leaving many 401k accounts overexpos...
American Hartford Gold | Sponsoredtc pixel
China is not hedging. It's escaping.
China's US Treasury holdings have fallen from a peak of $1.32 trillion to roughly $659 billion, an 18-year low...
Behind the Markets | Sponsoredtc pixel
A $5 stock inside Kennedy Space Center?
A small publicly traded company operates a specialized launch vehicle fleet inside the secure perimeter of Ken...
Freedom Financial | Sponsoredtc pixel
Free Stock Pick: The Company First in Line for America’s New Super Fuel
The U.S. Army and Department of Energy are launching Project Janus - a high-priority initiative ordered by Pre...
Banyan Hill Publishing | Sponsoredtc pixel
I’ll Keep This Short… (Huge AI Opportunity)
Analyst Ross Givens says the top AI opportunity right now isn't Microsoft, Google, Amazon, Apple, or Nvidia - ...
Traders Agency | Sponsoredtc pixel